Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9573000 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoid Leukemia
Intervention: Procedure: alloHCT

Study has passed its completion date and status has not been verified in more than two years.